SMS Lifesciences India Limited (SMSLIFE:NSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the SMS Lifesciences India Limited stock forecast from 0 analysts, the average analyst target price for SMS Lifesciences India Limited is not available over the next 12 months. SMS Lifesciences India Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SMS Lifesciences India Limited is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, SMS Lifesciences India Limited’s stock price was INR 725.00. SMS Lifesciences India Limited’s stock price has changed by +9.03% over the past week, +13.61% over the past month and +33.83% over the last year.
No recent analyst target price found for SMS Lifesciences India Limited
No recent average analyst rating found for SMS Lifesciences India Limited
Company Overview SMS Lifesciences India Limited
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products. The company was founded in 1990 and is based in Hyderabad, India. Read Less
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifunga...Read More
Frequently Asked Questions About SMS Lifesciences India Limited (SMSLIFE:NSE) Stock
Stock Target Advisor's fundamental analysis for SMS Lifesciences India Limited's stock is Slightly Bullish .
SMSLIFE:NSE stock's dividend yield is 0.23%.
Our analysis grades SMSLIFE:NSE stock's dividend yield at B-. This means that SMSLIFE:NSE stock's dividend yield is above 80% of the stocks in the Biotechnology sector in the NSE exchange.
Based on this SMSLIFE:NSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on SMSLIFE:NSE's stock to indicate what its average analyst target is.
SMSLIFE:NSE stock's Price/Earning ratio is 41.71.
Our analysis grades SMSLIFE:NSE stock's Price / Earning ratio at F. This means that SMSLIFE:NSE stock's Price/Earning ratio is above 50% of the stocks in the Biotechnology sector in the NSE exchange.
Based on this SMSLIFE:NSE may be fairly valued for its sector
The last closing price of SMSLIFE:NSE's stock was INR 725.00.
The most recent market capitalization for SMSLIFE:NSE is INR 2.05B.
Unfortunately we do not have enough analyst data on SMSLIFE:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains SMS Lifesciences India Limited's stock.
As per our most recent records SMS Lifesciences India Limited has 567 Employees.
SMS Lifesciences India Limited's registered address is Plot No. 19-III, Hyderabad, India, 500 096.
You can get more information about it from SMS Lifesciences India Limited's website at https://www.smslife.in.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SMSLIFE:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
